.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Baxter
McKinsey
Daiichi Sankyo
Accenture
Deloitte
McKesson
Farmers Insurance
Colorcon
Queensland Health
Cipla

Generated: September 19, 2017

DrugPatentWatch Database Preview

Ferring Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FERRING PHARMS INC, and what generic alternatives to FERRING PHARMS INC drugs are available?

FERRING PHARMS INC has six approved drugs.

There are two US patents protecting FERRING PHARMS INC drugs.

There are twenty-three patent family members on FERRING PHARMS INC drugs in sixteen countries.

Summary for Applicant: Ferring Pharms Inc

Patents:2
Tradenames:6
Ingredients:3
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-001Sep 6, 1995ABRXYesNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SOLUTION;NASAL017922-001Approved Prior to Jan 1, 1982ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
TABLET;ORAL019955-002Sep 6, 1995ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
PREPOPIK
citric acid; magnesium oxide; sodium picosulfate
FOR SOLUTION;ORAL202535-001Jul 16, 2012RXYesYes► Subscribe► SubscribeY ► Subscribe
Ferring Pharms Inc
STIMATE (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL020355-002Oct 24, 2007RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
INJECTABLE;INJECTION018938-001Mar 30, 1984APRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
CERVIDIL
dinoprostone
INSERT, EXTENDED RELEASE;VAGINAL020411-001Mar 30, 1995RXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP (NEEDS NO REFRIGERATION)
desmopressin acetate
SPRAY, METERED;NASAL017922-003Aug 7, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
STIMATE
desmopressin acetate
SPRAY, METERED;NASAL020355-001Mar 7, 1994DISCNNoNo► Subscribe► Subscribe► Subscribe
Ferring Pharms Inc
DDAVP
desmopressin acetate
SPRAY, METERED;NASAL017922-002Feb 6, 1989DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Ferring Pharms Inc

Paragraph IV activity for FERRING PHARMS INC drugs

Drugname Dosage Strength Tradename Submissiondate
sodium picosulfate, magnesium oxide and anhydrous citric acid
Oral Solution10 mg, 3.5 g, and 12 g
PREPOPIK
5/21/2014

International Patent Family for Ferring Pharms Inc Drugs

Country Document Number Estimated Expiration
Mexico2010003588► Subscribe
China101406457► Subscribe
European Patent Office2207526► Subscribe
Australia2008309287► Subscribe
Taiwan200924759► Subscribe
Russian Federation2473332► Subscribe
BrazilPI0818541► Subscribe
New Zealand583899► Subscribe
Canada2702152► Subscribe
Japan2011500549► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
AstraZeneca
Merck
QuintilesIMS
Novartis
McKinsey
Cerilliant
Dow
Baxter
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot